Raxibacumab, medically designated as PAmAb ABthrax, signifies a groundbreaking medication approach for the infection. This monoclonal protein, created by the company , specifically targets the protective antigen of Bacillus anthracis, effectively neutralizing its function to cause harm. The mecha